Boon Kua
Papers
5
Total Citations
120
H-Index
4
About
Boon Kua is a leading urological researcher whose work centers on improving the diagnosis and surgical management of prostate and renal cancers. His primary contributions lie in evaluating advanced imaging modalities—specifically, multiparametric magnetic resonance imaging (mpMRI) and ⁶⁸Ga-PSMA PET/CT—to enhance preoperative staging and predict pathological outcomes in prostate cancer. In a landmark 2020 study (69 citations), Kua systematically compared the predictive value of these two imaging techniques for radical prostatectomy outcomes, establishing a framework for more precise surgical planning. He further expanded this work in a 2021 analysis of over 1,100 men (33 citations), demonstrating that PSMA PET/CT can identify clinically significant cancers missed by mpMRI alone, thereby refining diagnostic and management strategies. Beyond prostate cancer, Kua co-developed the internationally recognized RPN (Radius, Position, iNvasion) classification and nephrometry scoring system (2023, 11 citations), a novel tool specifically designed to assess surgical difficulty for robotic partial nephrectomy. His research has directly influenced clinical guidelines, helping to reduce unnecessary biopsies and improve risk stratification. With cumulative citations exceeding 120, Kua’s work continues to shape evidence-based practice in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5